Market Overview

151516
Articles
3.00M
Views

Paul Quintaro

Benzinga Editor

June 03, 2015 7:30 AM
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that data from 11 abstracts (two oral pr ...
June 02, 2015 5:21 PM
HC2 Holdings, Inc. ("HC2") (NYSE: HCHC) announced today that it has sent a letter to MCG Capital Corporation ("MCGC") addressing inaccurate comments m ...
June 02, 2015 4:01 PM
LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company" or "we"), a leading vertically integrated global manufacturer, distributor and ...
June 02, 2015 8:06 AM
CoreLogic® (NYSE: CLGX), a leading global property information, analytics and data-enabled services provider, today released its April 2015 CoreLogic ...
June 02, 2015 7:03 AM
Ultragenyx Pharmaceutical Inc. (Nasdaq: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseas ...
June 01, 2015 4:15 PM
Today, Zions Bancorporation (NASDAQ: ZION) announced a corporate restructuring in conjunction with several expense and revenue initiatives that are ex ...
June 01, 2015 4:01 PM
Foundation Medicine, Inc. (NASDAQ: FMI) today announced new data demonstrating the role of MET exon 14 (METex14) alterations as drivers of growth of ...
June 01, 2015 3:45 PM
DEPCOM Power today announced it has reached an agreement to serve as the engineering, procurement and construction (EPC) firm on the Pawpaw Solar Faci ...
June 01, 2015 3:25 PM
Click Here 0 Best of Benzinga ...
June 01, 2015 2:17 PM
Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a clinical-stage pharmaceutical company, today announced the presentation of positive clinical data for ...
June 01, 2015 10:47 AM
Seattle Genetics, Inc. (Nasdaq: SGEN) today announced several ADCETRIS (brentuximab vedotin) data presentations in the AETHERA post-transplant consoli ...
June 01, 2015 10:36 AM
Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid tumor can ...
June 01, 2015 9:09 AM
OncoMed Pharmaceuticals Inc. (Nasdaq: OMED) presented new survival and biomarker data and updated clinical response and safety results from its Phase ...
June 01, 2015 9:06 AM
Aduro Biotech, Inc. (Nasdaq: ADRO) today announced the presentation of interim safety and efficacy data from an ongoing Phase 1b clinical trial of its ...

Get Benzinga's Newsletters